Collectively, these data support the neutralization of IFN-γ and TNF, or IL-1β in the post-acute stage of viral infection as viable therapeutic options to augment alveolar regeneration and dampen fibrotic sequelae observed following respiratory viral infections (Extended data Fig. 14). This evidence concerns the gene IFNG and viral infectious disease.